G1 Therapeutics, Inc. (GTHX)

G1 Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	128	158	233	434	684	993
Market Cap Growth	62.88%	-32.14%	-46.33%	-36.57%	-31.09%	39.49%
Enterprise Value	110	132	170	295	504	733
PE Ratio	-	-3.30	-1.58	-2.93	-6.90	-8.11
PS Ratio	1.52	1.92	4.54	13.79	15.11	-
PB Ratio	4.62	4.47	3.39	3.03	3.86	3.89
P/FCF Ratio	-12.40	-4.12	-1.80	-3.29	-8.19	-9.71
P/OCF Ratio	-12.40	-4.12	-1.81	-3.29	-8.17	-9.98
EV/Sales Ratio	1.31	1.60	3.32	9.36	11.14	-
EV/EBITDA Ratio	-11.48	-3.84	-1.26	-2.07	-5.28	-6.00
EV/EBIT Ratio	-11.17	-3.78	-1.26	-2.06	-5.25	-5.99
EV/FCF Ratio	-11.39	-3.43	-1.32	-2.23	-6.03	-7.17
Debt / Equity Ratio	1.70	1.58	1.20	0.57	0.16	0.04
Debt / EBITDA Ratio	-2.61	-1.63	-0.61	-0.58	-0.29	-0.08
Debt / FCF Ratio	-2.59	-1.46	-0.64	-0.62	-0.33	-0.09
Quick Ratio	2.36	3.20	4.40	8.23	8.87	13.64
Current Ratio	2.94	3.87	5.04	8.82	9.23	13.71
Asset Turnover	0.67	0.59	0.27	0.12	0.18	0
Interest Coverage	-2.08	-3.47	-12.98	-30.59	-54.03	-
Return on Equity (ROE)	-74.80%	-106.00%	-209.90%	-76.00%	-49.10%	-41.00%
Return on Assets (ROA)	-24.30%	-34.00%	-77.70%	-54.80%	-39.80%	-38.10%
Return on Capital (ROIC)	-30.51%	-43.30%	-89.96%	-63.18%	-47.04%	-48.68%
Earnings Yield	-23.88%	-30.34%	-63.33%	-34.17%	-14.50%	-12.33%
FCF Yield	-14.19%	-24.25%	-55.42%	-30.43%	-12.21%	-10.30%
Buyback Yield / Dilution	-1.01%	-18.58%	-4.01%	-10.73%	-1.01%	-12.55%
Total Shareholder Return	-1.01%	-18.58%	-4.01%	-10.73%	-1.01%	-12.55%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).